273 related articles for article (PubMed ID: 20211191)
21. Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine.
Napolitano F; Bonito-Oliva A; Federici M; Carta M; Errico F; Magara S; Martella G; Nisticò R; Centonze D; Pisani A; Gu HH; Mercuri NB; Usiello A
J Neurosci; 2010 Aug; 30(33):11043-56. PubMed ID: 20720111
[TBL] [Abstract][Full Text] [Related]
22. CB1 receptor knockout mice display reduced ethanol-induced conditioned place preference and increased striatal dopamine D2 receptors.
Houchi H; Babovic D; Pierrefiche O; Ledent C; Daoust M; Naassila M
Neuropsychopharmacology; 2005 Feb; 30(2):339-49. PubMed ID: 15383833
[TBL] [Abstract][Full Text] [Related]
23. Bidirectional regulation of dopamine D2 and neurotensin NTS1 receptors in dopamine neurons.
Jomphe C; Lemelin PL; Okano H; Kobayashi K; Trudeau LE
Eur J Neurosci; 2006 Nov; 24(10):2789-800. PubMed ID: 17116165
[TBL] [Abstract][Full Text] [Related]
24. Functional striatal hypodopaminergic activity in mice lacking adenosine A(2A) receptors.
Dassesse D; Massie A; Ferrari R; Ledent C; Parmentier M; Arckens L; Zoli M; Schiffmann SN
J Neurochem; 2001 Jul; 78(1):183-98. PubMed ID: 11432985
[TBL] [Abstract][Full Text] [Related]
25. Activation of neurotensin receptor type 1 attenuates locomotor activity.
Vadnie CA; Hinton DJ; Choi S; Choi Y; Ruby CL; Oliveros A; Prieto ML; Park JH; Choi DS
Neuropharmacology; 2014 Oct; 85():482-92. PubMed ID: 24929110
[TBL] [Abstract][Full Text] [Related]
26. Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice.
Gainetdinov RR; Bohn LM; Sotnikova TD; Cyr M; Laakso A; Macrae AD; Torres GE; Kim KM; Lefkowitz RJ; Caron MG; Premont RT
Neuron; 2003 Apr; 38(2):291-303. PubMed ID: 12718862
[TBL] [Abstract][Full Text] [Related]
27. Targeting neurotensin receptors with agonists and antagonists for therapeutic purposes.
Kitabgi P
Curr Opin Drug Discov Devel; 2002 Sep; 5(5):764-76. PubMed ID: 12630297
[TBL] [Abstract][Full Text] [Related]
28. Relevance of dopamine D(2)/neurotensin NTS1 and NMDA/neurotensin NTS1 receptor interaction in psychiatric and neurodegenerative disorders.
Tanganelli S; Antonelli T; Tomasini MC; Beggiato S; Fuxe K; Ferraro L
Curr Med Chem; 2012; 19(3):304-16. PubMed ID: 22335510
[TBL] [Abstract][Full Text] [Related]
29. Alpha1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates.
Drouin C; Darracq L; Trovero F; Blanc G; Glowinski J; Cotecchia S; Tassin JP
J Neurosci; 2002 Apr; 22(7):2873-84. PubMed ID: 11923452
[TBL] [Abstract][Full Text] [Related]
30. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.
Carta AR; Frau L; Pinna A; Pontis S; Simola N; Schintu N; Morelli M
Synapse; 2008 Jul; 62(7):524-33. PubMed ID: 18435422
[TBL] [Abstract][Full Text] [Related]
31. Galpha(olf) levels are regulated by receptor usage and control dopamine and adenosine action in the striatum.
Hervé D; Le Moine C; Corvol JC; Belluscio L; Ledent C; Fienberg AA; Jaber M; Studler JM; Girault JA
J Neurosci; 2001 Jun; 21(12):4390-9. PubMed ID: 11404425
[TBL] [Abstract][Full Text] [Related]
32. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T
Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626
[TBL] [Abstract][Full Text] [Related]
33. Involvement of NTS2 receptors in stress-induced analgesia.
Lafrance M; Roussy G; Belleville K; Maeno H; Beaudet N; Wada K; Sarret P
Neuroscience; 2010 Mar; 166(2):639-52. PubMed ID: 20035838
[TBL] [Abstract][Full Text] [Related]
34. Dopamine release is impaired in a mouse model of DYT1 dystonia.
Balcioglu A; Kim MO; Sharma N; Cha JH; Breakefield XO; Standaert DG
J Neurochem; 2007 Aug; 102(3):783-8. PubMed ID: 17550429
[TBL] [Abstract][Full Text] [Related]
35. d-Amphetamine-induced increase in neurotensin and neuropeptide Y outflow in the ventral striatum is mediated via stimulation of dopamine D1 and D2/3 receptors.
Gruber SH; Nomikos GG; Mathé AA
J Neurosci Res; 2002 Jul; 69(1):133-9. PubMed ID: 12111825
[TBL] [Abstract][Full Text] [Related]
36. Evidence for a role of NTS2 receptors in the modulation of tonic pain sensitivity.
Roussy G; Dansereau MA; Baudisson S; Ezzoubaa F; Belleville K; Beaudet N; Martinez J; Richelson E; Sarret P
Mol Pain; 2009 Jul; 5():38. PubMed ID: 19580660
[TBL] [Abstract][Full Text] [Related]
37. The Administration of Levocabastine, a NTS2 Receptor Antagonist, Modifies Na(+), K(+)-ATPase Properties.
Gutnisky A; López Ordieres MG; Rodríguez de Lores Arnaiz G
Neurochem Res; 2016 Jun; 41(6):1274-80. PubMed ID: 26738992
[TBL] [Abstract][Full Text] [Related]
38. Decrease of D2 receptor binding but increase in D2-stimulated G-protein activation, dopamine transporter binding and behavioural sensitization in brains of mice treated with a chronic escalating dose 'binge' cocaine administration paradigm.
Bailey A; Metaxas A; Yoo JH; McGee T; Kitchen I
Eur J Neurosci; 2008 Aug; 28(4):759-70. PubMed ID: 18671743
[TBL] [Abstract][Full Text] [Related]
39. Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism.
St-Hilaire M; Landry E; Lévesque D; Rouillard C
Neurobiol Dis; 2005 Nov; 20(2):450-60. PubMed ID: 15896973
[TBL] [Abstract][Full Text] [Related]
40. Hyperdopaminergia and altered locomotor activity in GABAB1-deficient mice.
Vacher CM; Gassmann M; Desrayaud S; Challet E; Bradaia A; Hoyer D; Waldmeier P; Kaupmann K; Pévet P; Bettler B
J Neurochem; 2006 May; 97(4):979-91. PubMed ID: 16606363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
